Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $548.00 ($4.6M) on 2026-07-02, disclosed to the SEC on 2026-07-02.
Scheduled sale ($4.6M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $548.00 | 658 | $361K | 7.9% |
| 2 | $548.73 | 258 | $142K | 3.1% |
| 3 | $550.02 | 384 | $211K | 4.6% |
| 4 | $551.30 | 1,467 | $809K | 17.6% |
| 5 | $552.61 | 1,818 | $1.0M | 21.9% |
| 6 | $553.52 | 2,201 |
| $1.2M |
| 26.6% |
| 7 | $554.45 | 299 | $166K | 3.6% |
| 8 | $555.83 | 990 | $550K | 12.0% |
| 9 | $556.36 | 225 | $125K | 2.7% |
| Total | $552.56 avg | 8,300 | $4.6M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-18 | $4.1M | — | Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |